Mometasone

Drug Usage Statistics, United States, 2013 - 2022

Mometasone Summary for 2022

Top drug rank	#311 ( 45)
Estimated number of prescriptions in the United States (2022)	264,224
Estimated number of patients in the United States (2022)	93,710

Average total drug cost (USD)
Per prescription	$121.64
Per day of therapy	$3.51/day
Average out-of-pocket cost (USD)
Per prescription	$8.38
Per day of therapy	$0.29/day

Total Prescriptions and Patients Per Year (2013 - 2022)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year	Rank	Change
2013	88	13
2014	117	29
2015	135	18
2016	167	32
2017	198	31

Year	Rank	Change
2018	222	24
2019	263	41
2020	231	32
2021	266	35
2022	311	45

Drug Cost Over Time (2013 - 2022)

Cost Per Prescription Fill: Average cost per filled prescription regardless of how many days of therapy the prescription is filled for (e.g. 10 days, 30 days, 90 days, etc.)
Cost per Day of Therapy: The average cost per prescription fill divided by the days of therapy. For example, a 10-day antibiotic course costing $30 would be $3 per day. Similarly, a 30-day supply of an oral antihypetensive costing $30 would be $1 per day.

Total cost: The average total cost of the medication including the out-of-pocket cost (see below) plus the amount paid by other parties (Medicare, Medicaid, private insurance, Veterans Administration, TRICARE, other state/federal sources, Worker's compensation, and other miscellaneous sources)
Out-of-pocket cost: The average payment made by the patient which may include deductibles, coinsurance, copayments, or the cash price paid without insurance coverage.

Cost Per Prescription Fill (USD)

Cost Per Day of Therapy (USD/day)

Distribution of Dispensed Dosage Forms (2022)

Dosage Form	Strength	% of Dispensed Products
Suppository	50 mcg/act	100.0%

Distribution of Days Supplied (2022)

"Days supply" is defined as the number of days that a prescription should last. For example, a prescription of 60 tablets that is taken twice daily has a day supply of 30 days.

Related Drugs

Drug Name	Total Prescriptions (2022)
Fluticasone	22,557,459
Prednisone	18,201,857
Fluticasone; Salmeterol	11,570,694
Budesonide; Formoterol	8,225,093
Triamcinolone	6,216,925
Prednisolone	4,327,570
Fluticasone; Umeclidinium; Vilanterol	3,919,608
Fluticasone; Vilanterol	3,879,209
Methylprednisolone	3,595,227
Clobetasol	3,528,926
Budesonide	2,800,250
Hydrocortisone	2,010,949
Dexamethasone	1,524,944
Betamethasone; Clotrimazole	1,401,057
Betamethasone	1,058,996
Fluocinonide	1,018,705
Dexamethasone; Neomycin; Polymyxin B	831,263
Ciprofloxacin; Dexamethasone	543,930
Neomycin; Polymyxin B; Hydrocortisone	418,235
Azelastine; Fluticasone	394,381
Mometasone (this drug)	264,224
Fluocinolone; Hydroquinone; Tretinoin	43,056

Therapeutic Classes

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms

Asmanex Hfa
Asmanex Twisthaler
Elocon
Nasonex
Sinuva
Nasonex 24hr Allergy

Generic Drug Synonyms and Salts

Mometasone Furoate
Mometasone Furoate Monohydrate
Mometasone

FDA Approval Information

Established Pharmacologic Class (EPC):	Corticosteroid
Initial FDA approval date:	4/30/1987
First FDA applicant:	Discn
First dosage form:	Ointment (topical)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2013-2022. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2024.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Mailing List

Get Email Updates

New and Popular

Open Menu

Cite This Page

Show AMA citation

Disclaimer - Privacy Policy - Contact Us
Updated Sep 12, 2021

Top